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Introduction
Spindle cell carcinoma (SpCC), also known as sarco-
matoid carcinoma, is a rare malignancy of the head and
neck regions. It is most frequently encountered in the
larynx, and also occurs in the nasal cavity, hypopharynx,
oral cavities, esophagus, trachea, skin and breast. In 
a previous series of laryngeal malignancy, about 1%
were diagnosed with SpCC.1 Male predominance was
also noted.
SpCC is an unusual form of poorly differentiated
squamous cell carcinoma (SCC) consisting of elongated
(spindle) epithelial cells that resemble a sarcoma. Many
of these tumors may be easily confused with true sarco-
mas unless special immunohistologic or ultrastructural
analysis is performed. Such analyses show concurrent
presence of malignant epithelial and homologous sar-
comatoid spindle cell components by co-expression of
cytokeratin, epithelial membrane antigen, and vimentin
to various degrees.2,3
The spindle cell components have been consid-
ered to be either a variant growth pattern of SCC, a
non-neoplastic mesenchymal reaction, or a malignant
admixture of epithelial and mesenchymal neoplasms.4
However, the majority of the spindle cell components
are non-diploid, which indicates that they are neoplas-
tic and not reactive.5 The vimentin positivity reflects
that these bizarre fibroblast-like cells are carcinoma cells
with true mesenchymal metaplasia. Electron micro-
scopy often shows the presence of junctional complexes
between tumor cells, with or without pericellular basal
lamina and cytoplasmic skeins of intermediate filaments.6
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When the spindle cell component was compared with
its corresponding epithelial component, identical pat-
terns of p53 protein expression were noted in 95% 
of the biphasic tumors.7 These comprise evidence that
the malignant spindle cells are due to metaplasia from
the involved epithelium, not inflammatory reaction or
true sarcoma.
To the authors’ knowledge, the only published
series of more than 10 cases of SpCC in the oral cavity
was reported about 25 years ago.8 In the current study,
we report 18 new cases of SpCC, review the factors
significant for influencing outcome, and outline the
surgical management of these lesions.
Methods
A search of records in Kaohsiung Veterans General
Hospital between 1994 and 2005 yielded 18 lesions in
17 patients diagnosed with SpCC in the oral cavity and
oropharynx. A retrospective chart review was performed
to assess clinical presentation, surgical management,
and recurrence. The surgical intervention included
wide excision of local tumor with a safety margin of
about 1–2 cm, and neck dissection for possible neck
disease. Patient-related factors including age, gender,
and hazardous habits (cigarette, alcohol or betel nut
consumption), and tumor-related factors including
the AJCC (American Joint Committee on Cancer)
stage, treatment, pathologic findings (surgical margin,
tumor invasion, multi-foci, tumor necrosis, poor dif-
ferentiation), and recurrence pattern were grouped and
analyzed (Table 1).
To make a diagnosis of SpCC in a sarcomatoid 
tumor, the following criteria had to be met: (1) 
identification of carcinoma, particularly with some-
what squamoid feature, in some part of the tumor
(Figures 1 and 2); (2) spindle cells stain positively for
cytokeratin and may also have negativity for vimentin
(Figures 3 and 4); (3) presence of SCC in situ.
The Kaplan–Meier model with log rank test was
performed for survival analysis. Fisher’s exact test and
Student’s t test were used to determine the relation-
ship between the variables and recurrent pattern. The
Mann–Whitney test was used to compare the relation-
ship between time to recurrence and salvage operation.
A p value<0.05 was considered statistically significant.
Results
Eighteen lesions of different portions from the oral
cavity and oropharynx were found. There were 17 men
(94%) and 1 woman (6%). The median age at onset
was 51 years (range, 32–76 years). The mean follow-
up time was 14.2 months. The most common disease
sites were the tongue (28%) and buccal mucosa (22%).
According to the 2002 AJCC cancer staging system,
there were 3 cases with stage I disease, 3 cases with
stage II, 2 cases with stage III, 9 cases with stage IV,
and 1 case without definite staging.
The median overall survival time was 8.9 months.
The 1-year overall survival rate was 36.7%, and the 
3-year overall survival rate was 27.5%. In the early stage
group (stages I and II), the 3-year survival rate was
100%. In the late stage group (stages III and IV), the
1-year survival rate was only 9%, and the 3-year sur-
vival rate was 0%. Survival time difference between the
early and late stage groups was statistically significant.
The factors influencing overall survival were tumor
grade, lymph nodes, metastasis, stage, vascular invasion
and distant recurrence (Table 2). The following fac-
tors did not statistically significantly influence survival:
gender, age, tumor site, previous existence of SCC,
cigarette smoking, alcohol drinking, betel nut chew-
ing, positive surgical margin, distance of safe margin,
nerve invasion, muscular invasion, tumor necrosis,
multi-foci, radiotherapy, chemotherapy, combined treat-
ment of surgery and radiotherapy, and local recurrence.
A total of 15 patients received surgery, 1 received
chemotherapy only, 1 received radiotherapy only, and
1 refused any treatment. In the surgery group, 11
developed local recurrence (recurrence rate, 73.3%).
Even the early stage group with negative surgical
margin had recurrence. Four patients had local recur-
rence with regional lymph node metastases; 5 patients
had distant metastases (metastasis rate, 33.3%) and
subsequently died of metastatic disease.
Seven of the 11 patients with local recurrence
received salvage operation and responded well. Salvage
operation after local recurrence improved survival (Table
3). The post-recurrence survival was defined as the time
interval of survival between the patient’s recurrence and
the end of the study. The median post-recurrence sur-
vival was 22 months for patients who received salvage
surgery and only 1 month for patients who did not
receive salvage surgery. The relationship between over-
all survival and salvage operation was also statistically
significant. The mean overall survival was 34 months
in patients who received salvage surgery and 4 months
in those who did not.
The recurrence time was determined as the time
interval from treatment to recurrence. The median over-
all recurrence time was 5.2 months. The median recur-
rence time in the early stage group was 10.5 months,
versus 4.0 months in the late stage group (p = 0.03).
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The median recurrence time in patients managed with
salvage operation was 8 months, whereas it was 2
months in patients who did not receive salvage opera-
tion (p = 0.014). This suggests that if recurrence time is
shorter, the opportunity to perform salvage operation
will be lower. The possible cause was that late stage
patients experienced recurrence earlier and so usually
could not receive surgery. The factors influencing sur-
vival after recurrence are listed in Table 3.
After recurrence, having salvage operation or not
was influenced by the initial staging factor of T, N
and stage (p < 0.01). This suggests that the higher the
initial stage of a patient, the less likely it is that he will
receive salvage operation after recurrence.
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Figure 3. Spindle cell carcinoma of the buccal mucosa shows
positive staining in both sarcomatoid and carcinomatoid cells
(cytokeratin; 200×).
Figure 4. Spindle cell carcinoma of the buccal mucosa shows
negative staining in both sarcomatoid and carcinomatoid cells
(vimentin; 200×).
Figure 1. Spindle cell carcinoma of the buccal mucosa: there is
presence of both carcinoma in situ (short arrow) and sarcoma-
tous components (long arrow) (hematoxylin & eosin; 20×).
Figure 2. Spindle cell carcinoma of the buccal mucosa with pre-
dominance of sarcomatoid components and scattered carcino-
matoid elements (left upper corner) (hematoxylin & eosin; 100×).
Table 2. Significant factors influencing overall survival
p
T (1, 2; 3, 4) < 0.001
N (0; 1–3) 0.004
Early stage (I, II)/late stage (III, IV) < 0.001
Neck or distant metastasis < 0.001
Vascular invasion 0.005
Distant recurrence 0.042
Table 3. Significant factors influencing post-recurrence survival
p
T (1, 2; 3, 4) < 0.001
Early stage (I, II)/late stage (III, IV) 0.017
Distant recurrence 0.026
Salvage operation < 0.001
No patient with recurrence had positive margin dur-
ing the previous surgery. We used Fisher’s exact test to
detect the factors influencing the failure pattern. The
significant factor for local recurrence was alcohol con-
sumption (p = 0.03). There were no significant factors
for regional recurrence, but muscular invasion (p=0.05)
was noteworthy. The significant factors for distant meta-
stasis were age < 50 years (p = 0.03), T stage > T2 (p =
0.03), and nerve invasion (p = 0.007).
Discussion
The spindle cells in SpCC are a variant growth pattern
of SCC, neither a non-neoplastic mesenchymal reaction
nor a malignant admixture of epithelial and mesenchy-
mal neoplasms. The epithelial and spindle components
share a common pathway of tumorigenesis despite their
conspicuous divergence at the phenotypic level.7 Here,
the question arises, “Is the behavior of SpCC different
from that of SCC?”
The survival and reaction to treatment of SpCC are
still controversial. Ellis et al8 reported 59 cases of oral
SpCC with a 36% survival rate. Olsen et al9 reported
34 patients with laryngeal and hypopharyngeal SpCC;
recurrence occurred in 10 patients, 8 patients died of
their disease, and the 3-year survival rate was 56.8%.
Olsen et al considered that SpCC was similar to con-
ventional SCC of the larynx, but there were only 2
cases of stage III and 2 cases of stage IV in their series.
In our series, the overall survival rate of oral SpCC was
27.5% at 3 years. This low survival rate might be due
to there being many late-stage patients in our series. In
our early stage group, the 3-year survival rate was 100%.
In contrast, half the patients in our late stage group
died within 6 months. Leventon et al10 found that sur-
vival was related to depth of invasion; in patients whose
tumors invaded deeply, survival rate was low, whereas
in those whose tumors were superficial, survival pro-
spects were excellent.
Alonso et al11 found that SpCC demonstrated pro-
minent local invasiveness, high angiogenic response, and
a 90–100% incidence of lung metastases when inocu-
lated subcutaneously into syngeneic mice. It is known
that in the inflammatory state, the epithelioid cell might
change its shape into the spindle morphology to aid in
migration. Kaposi’s sarcoma is another famous example,
which is characterized by spindle cell proliferation, in-
flammatory cell infiltration, angiogenesis, edema, and
invasiveness.12 These facts suggest that the spindle cell
pattern might be linked with invasiveness and metastasis.
In our series, the overall survival rate was lower
than that of SCC in the oral cavity and oropharynx.13
The recurrence rate was very high, even in the early-
stage patients. The metastatic rate was high in the
advanced-stage patients. We would consider that oral
and oropharyngeal SpCC has more aggressive behav-
ior. Better treatment of oral SpCC should be aimed at
controlling local and distant recurrence.
It appeared strange that none of the patients with
local recurrence had positive margin during the initial
surgery. The distance of surgical margin was not statis-
tically significant to the recurrence. To improve local
control, a much wider safety margin (> 2 cm) for
SpCC would be helpful. To identify the recurrence
early, close postoperative follow-up is necessary. If
recurrence occurs, salvage operation is indicated and
is helpful.
In general, results using radiation therapy alone to
treat SpCC have not been satisfactory.14 Olsen et al had
1 case of T1 glottic carcinoma with favorable response
to radiotherapy alone without recurrence 49 months
after diagnosis. Ampil15 reported that 2 of 4 cases
benefited from the combination of surgery and radio-
therapy. The influence of radiotherapy on outcome in
our series was not statistically significant. But 1 of our
patients with a positive surgical margin did benefit
from adjuvant radiotherapy. Therefore, we consider that
radiation therapy might be helpful in improving local
control in patients with positive surgical margins.
Colozza et al16 reported an amazing experience of
chemotherapy for a patient who had neck and lung
metastases by SpCC from an unknown primary site.
The patient had a complete response to cisplatin and
5-fluorouracil, and was disease-free 12 months after
diagnosis. However, such was not the case for our
patient with metastasis. To solve the problem of dis-
tant recurrence, chemotherapy will still play a role in
the future. Considering the high angiogenic response
of SpCC,11 patients with tumor stage > T2 (included)
may require chemotherapy to decrease the risk of 
distant metastasis or regional failure.
In conclusion, SpCC in the oral cavity and oro-
pharynx is potentially aggressive and seems to recur
easily and to metastasize. It should be treated accord-
ingly, and better treatment of oral SpCC should aim at
controlling local and distant recurrence. Although it is
difficult to predict biologic behavior in every case,
patients whose tumors are deeply invasive tend to have
a poor prognosis, whereas those with early-stage tumors
usually have an excellent prognosis. If local recurrence
occurs, salvage operation should be performed and will
be beneficial to patients.
Based on the limited number of patients in this
study, it would be helpful if more cases were collected
for meta-analysis from a multicenter data bank to
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answer further questions about the behavior and opti-
mal treatment of SpCC.
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